Tuberculosis (TB) is no longer the death sentence it once was, but drug-resistant strains and systemic gaps threaten global progress. WHO data reveals a chilling reality: In 2023, 30,000 people fell ill daily with TB worldwide, while 3,500 lost their lives each day.
China’s Fight: Grassroots & Tech Take Center Stage
The Chinese mainland is rolling out a 2024-2030 TB control plan, prioritizing early detection and affordable care. Yet challenges persist: low diagnosis rates, high costs, and drug-resistant strains. China reported 29,000 multidrug-resistant TB cases in 2023—7.3% of the global total.
AI, Tongue Swabs & Hope
Innovations like AI-powered diagnostics and rapid tongue-swab tests are game-changers, matching global standards. Experts at a Beijing seminar co-hosted by Peking University stressed that shorter treatment regimens and tech scaling are key. “Drug-resistant TB requires complex, costly treatments,” warned Zhang Hui of China’s National TB Center.
A Global Race Against Time
With WHO’s 2030 TB eradication target looming, cross-border collaboration and youth-aware campaigns are vital. As Zhao Yanlin, China’s top TB official, puts it: “Ending TB needs everyone’s voice.”
New Tech Battles Drug-Resistant TB: Can Innovation Save Lives? 
China’s Fight: Grassroots & Tech Take Center Stage
AI, Tongue Swabs & Hope
A Global Race Against Time
Chinese mRNA TB Vaccine Enters Trials: A Game-Changer?
